Skip to content

Interest in CDK4 at AACR 2025

CDK4 Update – Benchmark Antibodies

Hello Scientist,

Another busy AACR is in the books! We followed several interesting topics this year, but notably CDK4 was one of the most frequently studied targets of interest.

Benchmark Antibodies has now expanded the premium IVD for R&D reagent catalogue to include diagnostic grade CDK4 antibody clones:

  • Rabbit Anti-CDK4 monoclonal antibody (ZR394) 6118

  • IVD for R&D precision antibodies are developed by pathologists to provide diagnostic grade target specificity and reproducibility validated reagents for your IHC research applications.

    Why use IVD reagents for research applications? The IVD for R&D clones are invaluable for eliminating the guess-work and inconsistencies of research grade reagents.

    IVD for R&D Rabbit Anti-CDK4 monoclonal antibody (ZR394) 6118
  • RELIABLE QUALITY
    – ISO/GMP monoclonal manufacturing and IVD validation guarantees batch consistency and reproducibility
  • ECONOMICAL
    – IVD workflow reagents ensure uninterrupted supply and lowest market prices
  • EASY-TO-USE
    – Well characterized protocols with real-time North American technical support and order fulfillment
  • Formalin-fixed, paraffin-embedded human liposarcoma.
    Formalin-fixed, paraffin-embedded human liposarcoma stained with anti-CDK4 antibody using peroxidase-conjugate and DAB chromogen. Note nuclear/cytoplasmic staining of tumor cells.

    TECHNICAL RESOURCES:
  • Immunohistochemistry Protocol
  • Anti-CDK4 rabbit monoclonal antibody (ZR394) 6118
  • Please visit us and feel free to contact us if you have any questions or if we can provide you with additional information.
    We look forward to hearing from you!

    Best regards,
    Team Benchmark

    Visit Our Website
    Contact Us
    (650) 746-4228
    Benchmark Antibodies
    Facebook Twitter LinkedIn Instagram